Latest Breaking News On - John temperato - Page 1 : vimarsana.com

9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome

RALEIGH, NC / ACCESSWIRE / May 30, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced

Bethany sensenigAl medwarMark sirgoMeters biopharma inc viewInvestor relations corporate communicationsMeters biopharma incDrug administrationJohn temperatoChief executive officerChief financial officerAnnual reportQuarterly reportsInvestor relationsInc viewGefallene big techs

9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome

9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

Al medwarBethany sensenigMark sirgoMeters biopharma incDrug administrationInvestor relations corporate communicationsJohn temperatoChief executive officerChief financial officerRisk factorAnnual reportQuarterly reportsInvestor relations

9 Meters Biopharma (NMTR) Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome

9 Meters Biopharma (NMTR) Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bethany sensenigMark sirgoMeters biopharma incDrug administrationJohn temperatoChief executive officerChief financial officer

9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome

9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

Mark sirgoAl medwarBethany sensenigMeters biopharma incInvestor relations corporate communicationsDrug administrationJohn temperatoChief executive officerChief financial officerRisk factorAnnual reportQuarterly reportsInvestor relations

9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2023

9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2023
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

United statesJohn temperatoAl medwarMeters biopharma incInvestor relations corporate communicationsClinical developmentChief executive officerInvestigational new drugDigestive disease weekRisk factorAnnual reportQuarterly reportsInvestor relationsUnited states wire group